Matthew L. Scherer

Psychosocial Factors and the Care Cascade for Hepatitis C Treatment Colocated at a Syringe Service Program.

P. Gordon, Matthew L Scherer, Pantelis Antoniou, 2020, The Journal of infectious diseases.

Preliminary Screening Results Outside the 1945–1965 Birth Cohort: A Forgotten Population for Hepatitis C?

E. Verna, P. Gordon, J. Zucker, 2018, Open forum infectious diseases.

Clinical Characteristics and Outcomes in People Living With Human Immunodeficiency Virus Hospitalized for Coronavirus Disease 2019

Noga Shalev, M. Yin, J. Zucker, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Pretest Symptom Duration and Cycle Threshold Values for Severe Acute Respiratory Syndrome Coronavirus 2 Reverse-Transcription Polymerase Chain Reaction Predict Coronavirus Disease 2019 Mortality

M. Yin, L. Kuhn, A. Uhlemann, 2021, Open forum infectious diseases.

Antiretroviral Drug Recommendations for HIV Treatment and Prevention.

Noga Shalev, K. Brudney, Matthew L. Scherer, 2021, JAMA.

Hepatitis C Treatment Outcomes for People Who Inject Drugs Treated in an Accessible Care Program Located at a Syringe Service Program

B. Edlin, K. Marks, Emily R Winkelstein, 2018, Open forum infectious diseases.

Individualized Provider Feedback Increased HIV and HCV Screening and Identification in a New York City Emergency Department.

Simian Huang, P. Gordon, J. Zucker, 2022, AIDS patient care and STDs.

Attitudes and Perceived Barriers to Routine HIV Screening and Provision and Linkage of Postexposure Prophylaxis and Pre-Exposure Prophylaxis Among Graduate Medical Trainees.

A. Cohall, P. Gordon, J. Zucker, 2021, AIDS patient care and STDs.